Cytochrome P450 1B1 and 2C9 Genotypes and Risk of Ischemic Vascular Disease, Cancer, and Chronic Obstructive Pulmonary Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|10|4|512-520

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.10, Iss.4, 2012-01, pp. : 512-520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study

By Carlquist John Horne Benjamin Muhlestein Joseph Lappé Donald Whiting Bryant Kolek Matthew Clarke Jessica James Brent Anderson Jeffrey

Journal of Thrombosis and Thrombolysis, Vol. 22, Iss. 3, 2006-12 ,pp. : 191-197

Springer Publishing Company

Access to resources Recommend Favorite

Modifying the Course of Chronic Obstructive Pulmonary Disease: Looking Beyond the FEV₁

By ZuWallack Richard L. Nici Linda

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 9, Iss. 6, 2012-11 ,pp. : 637-648

Informa Healthcare

Access to resources Recommend Favorite

Chronic Obstructive Pulmonary Disease and Vascular Disease Delay Timeliness of Early Stage Lung Cancer Resectional Surgery

By Seda Gilbert Stafford Christopher C. Parrish John S. Praske Steven P. Daheshia Massoud

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 2, 2013-03 ,pp. : 133-137

Informa Healthcare

Access to resources Recommend Favorite

Chronic Obstructive Pulmonary Disease

Medical Principles and Practice, Vol. 7, Iss. 1, 1998-04 ,pp. : 1-17

Karger

Access to resources Recommend Favorite

Surfactant Protein D, Soluble Intercellular Adhesion Molecule-1 and High-Sensitivity C-Reactive Protein as Biomarkers of Chronic Obstructive Pulmonary Disease

Medical Principles and Practice, Vol. 22, Iss. 5, 2013-07 ,pp. : 469-474

Karger

Access to resources Recommend Favorite